“…Recent studies reported that extracts from A. tegmentosum possessed various therapeutic effects in in vitro and in vivo model systems, including hepatoprotection (Park et al, 2019), alleviation of alcohol-induced liver injury and steatosis (Lee Y. et al, 2017), antioxidant and anti-inflammation (Kim et al, 2012), suppression of atopic dermatitis (Yang et al, 1; Hou et al, 2019, 2;Kim et al, 2012, 3;Lee et al, 2017a, 4;Lee et al, 2014, 5;Park et al, 2006, 6;Piao et al, 2020, 7;Tung et al, 2008 2016), reduction of bone destruction (Ha et al, 2014), and antidepressant activity (Park et al, 2020a). The complete list of compounds contained in A. tegmentosum have not been reported yet, but to date, 44 compounds have been identified (Park et al, 2006;Tung et al, 2008;Kim et al, 2012;Lee et al, 2014;Lee et al, 2017a;Hou et al, 2019;Piao et al, 2020): 24 flavonoids (e.g., quercitrin, catechin, kaempferol-3-rhamnoside, erigeside B, feniculin, and avicularin), 10 phenolic glycosides (e.g., salidroside, 6′-O-galloylsalidroside, and 3,5-dimethoxy-4hydroxyphenyl-I-O-β-D-glucoside), 3 phenolic acids (gallic acid, methyl gallate, and 3,4-dihydroxybenzoic acid), 2 phenylpropanoid glycosides (eutigoside A and grayanoside A), 2 courmarins (fraxin and scopoletin), 1 quinone (2,6-dimethoxyρ-hydroquinone), 1 phenylethyl alcohol (tyrosol), and 1 steroidal glycoside (β-sitosterol 3-O-β-D-glucopyranoside) (the complete list is available in Table 1). Among these, several compounds have been known to provide beneficial effects in human diseases such as cancer, cardiovascular diseases, and neurodegenerative diseases (Nijveldt et al, 2001;Jucá et al, 2020).…”